Dialysis-dependent Chronic Kidney Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2018-11-05
Clinical Trial Update: Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) [Phase 3]
Phase 3 trial evaluating three-times-per-week oral dosing of vadadustat for anemia in dialysis-dependent CKD has been withdrawn.